What is Small Intestinal Bacterial Overgrowth (SIBO). How does SIBO affect digestive health. What are the common symptoms of SIBO. What causes SIBO and who is at risk. How is SIBO diagnosed and treated. What dietary changes can help manage SIBO. How can SIBO complications be prevented.

Understanding Small Intestinal Bacterial Overgrowth (SIBO)

Small Intestinal Bacterial Overgrowth, commonly known as SIBO, is a condition characterized by an excessive amount of bacteria in the small intestine. While bacteria play a crucial role in digestion, an imbalance can lead to various digestive issues. SIBO occurs when the delicate equilibrium of gut bacteria is disrupted, allowing harmful bacteria to proliferate and dominate the small intestine.

Is SIBO a serious condition? While SIBO can cause significant discomfort and impact quality of life, it is generally treatable. With proper diagnosis and management, most individuals can effectively control their symptoms and restore gut health.

Recognizing SIBO Symptoms

SIBO can manifest through a variety of symptoms, which may vary in intensity from person to person. Common signs include:

• Abdominal pain and discomfort
• Bloating and excessive gas
• Nausea and loss of appetite
• Diarrhea or constipation
• Fatigue and weakness
• Uncomfortable fullness after eating

Can SIBO symptoms mimic other digestive disorders? Indeed, SIBO symptoms can often be mistaken for other gastrointestinal conditions such as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). This similarity in symptoms underscores the importance of proper diagnosis by a healthcare professional.

Causes and Risk Factors for SIBO

SIBO typically develops when the natural mechanisms that control bacterial growth in the small intestine are compromised. Several factors can contribute to this imbalance:

Anatomical Factors

Structural abnormalities in the small intestine can impede the normal flow of food and bacteria, creating an environment conducive to bacterial overgrowth. These may include:

• Diverticulosis (pouches in the intestinal lining)
• Scarring from surgeries or radiation therapy
• Fistulas (abnormal connections between parts of the bowel)
• Intestinal obstructions

Medical Conditions

Certain health conditions can increase the risk of developing SIBO:

• Diabetes
• Autoimmune diseases like lupus and scleroderma
• Immunodeficiency disorders
• Inflammatory bowel diseases (Crohn’s disease and ulcerative colitis)

Medications

Some medications can alter the gut environment, potentially leading to SIBO:

• Proton pump inhibitors (PPIs)
• Narcotics
• Certain antibiotics
• Drugs used to treat irritable bowel syndrome

Does age play a role in SIBO development? Yes, older adults are at higher risk for SIBO due to decreased gastric acid production and a higher likelihood of developing conditions like diverticulosis.

Diagnosing SIBO: Tests and Procedures

Diagnosing SIBO can be challenging due to the overlap of symptoms with other digestive disorders. Gastroenterologists typically employ a combination of clinical assessment and diagnostic tests to confirm SIBO:

Hydrogen Breath Test

This non-invasive test is commonly used to diagnose SIBO. Patients drink a sugar solution, and their breath is analyzed for hydrogen or methane content over several hours. Elevated levels of these gases can indicate bacterial overgrowth in the small intestine.

Small Intestine Aspirate and Fluid Culture

This more invasive procedure involves collecting a fluid sample directly from the small intestine using an endoscope. The sample is then cultured to identify and quantify bacterial species present.

Imaging Studies

X-rays, CT scans, or MRI may be used to detect structural abnormalities in the small intestine that could contribute to SIBO.

Blood and Stool Tests

These tests can help identify nutritional deficiencies or malabsorption issues often associated with SIBO.

Are there any new diagnostic methods for SIBO? Research is ongoing to develop more accurate and less invasive diagnostic tools for SIBO, including advanced breath testing techniques and gut microbiome analysis.

SIBO Treatment Strategies

The primary goal of SIBO treatment is to restore balance to the gut microbiome and alleviate symptoms. Treatment approaches may include:

Antibiotic Therapy

Antibiotics are often the first-line treatment for SIBO. Commonly prescribed antibiotics include:

• Rifaximin (Xifaxan)
• Neomycin
• Metronidazole (Flagyl)
• Ciprofloxacin (Cipro)

The choice of antibiotic may depend on the type of bacterial overgrowth identified through testing.

Nutritional Support

SIBO can lead to nutrient deficiencies due to malabsorption. Supplementation with vitamins and minerals, particularly vitamin B12, iron, and fat-soluble vitamins, may be necessary.

Prokinetics

These medications help improve intestinal motility, reducing the risk of bacterial overgrowth. They may be prescribed in cases where slow gut motility is a contributing factor to SIBO.

Surgical Intervention

In rare cases where SIBO is caused by structural abnormalities, surgical correction may be necessary to prevent recurrence.

How long does SIBO treatment typically last? The duration of treatment can vary depending on the severity of the condition and individual response. Some patients may require only a short course of antibiotics, while others may need longer-term management strategies.

Dietary Approaches for Managing SIBO

Diet plays a crucial role in managing SIBO and preventing recurrence. While there is no one-size-fits-all approach, several dietary strategies have shown promise:

Low FODMAP Diet

This diet restricts fermentable carbohydrates that can feed harmful bacteria. It involves eliminating or reducing intake of certain fruits, vegetables, dairy products, and grains.

Elemental Diet

This liquid diet provides nutrients in their simplest form, allowing for easy absorption and reducing the food available for bacterial fermentation. It is typically used for short periods under medical supervision.

Specific Carbohydrate Diet (SCD)

This diet eliminates complex carbohydrates and processed foods, focusing on easily digestible nutrients that are less likely to feed harmful bacteria.

Gut-Healing Foods

Incorporating foods that support gut health can be beneficial:

• Bone broth
• Fermented foods (in moderation)
• Prebiotic-rich foods (after initial treatment)
• Anti-inflammatory herbs and spices

Can dietary changes alone cure SIBO? While dietary modifications are an important component of SIBO management, they are typically most effective when combined with medical treatment. Diet alone may not be sufficient to eradicate bacterial overgrowth in severe cases.

Preventing SIBO Complications and Recurrence

SIBO, if left untreated or poorly managed, can lead to various complications:

• Malnutrition and vitamin deficiencies
• Osteoporosis due to calcium malabsorption
• Kidney stones
• Neuropathy

To prevent these complications and reduce the risk of SIBO recurrence, consider the following strategies:

Regular Follow-Up Care

Maintaining regular check-ups with a gastroenterologist can help monitor the condition and adjust treatment as needed.

Lifestyle Modifications

Adopting healthy habits can support overall gut health:

• Stress management techniques
• Regular exercise
• Adequate sleep
• Smoking cessation

Proactive Dietary Management

Continuing to follow a gut-friendly diet even after symptoms improve can help maintain bacterial balance and prevent recurrence.

Addressing Underlying Conditions

Managing any underlying health conditions that may contribute to SIBO is crucial for long-term prevention.

How often does SIBO recur? Recurrence rates for SIBO can be high, with some studies suggesting that up to 40% of patients may experience a return of symptoms within a year. This underscores the importance of ongoing management and preventive strategies.

Emerging Research and Future Directions in SIBO Management

The field of SIBO research is rapidly evolving, with new insights and potential treatments on the horizon:

Microbiome Manipulation

Researchers are exploring ways to directly modulate the gut microbiome to treat SIBO, including:

• Targeted probiotics
• Fecal microbiota transplantation (FMT)
• Bacteriophage therapy

Advanced Diagnostic Techniques

New diagnostic methods are being developed to improve the accuracy and ease of SIBO detection:

• Capsule endoscopy with bacterial sampling capabilities
• Advanced breath testing protocols
• Genetic testing for susceptibility to SIBO

Personalized Treatment Approaches

The future of SIBO management may involve more personalized strategies based on individual microbiome profiles and genetic factors.

What role does the gut-brain axis play in SIBO? Emerging research suggests a complex interplay between gut health and neurological function. Understanding this connection may lead to novel treatment approaches that address both gastrointestinal and neurological symptoms associated with SIBO.

In conclusion, Small Intestinal Bacterial Overgrowth is a complex condition that requires a multifaceted approach to diagnosis and treatment. By understanding the underlying causes, recognizing symptoms, and implementing appropriate management strategies, individuals with SIBO can significantly improve their quality of life and digestive health. As research continues to advance our understanding of the gut microbiome, we can look forward to more targeted and effective treatments for SIBO in the future.

Small Intestinal Bacterial Overgrowth (SIBO)

Written by Caitlin Cox

• What Is SIBO?
• SIBO Symptoms
• SIBO Causes and Risk Factors
• SIBO Diagnosis
• SIBO Treatment
• SIBO Diet
• SIBO Complications
• More

Small intestinal bacterial overgrowth (SIBO) is when you have too much bacteria in your small intestine.

Everyone has bacteria in their gut; they play a key part in digestion. But if things get out of balance, problems can happen.

SIBO can be treated, and lifestyle changes may be all it takes.

SIBO may cause:

• Belly pain
• Queasiness
• Bloating
• Uncomfortable fullness after eating
• Loss of appetite
• Indigestion
• Passing a lot of gas
• Diarrhea or constipation
• Fatigue
• Weakness

SIBO usually starts when your small intestine doesn’t move food along the way it should. Bacteria grow and stick around too long. If the “good” bacteria that help you digest food can’t keep up with the harmful bacteria, the “bad” germs can multiply too fast, leading to an imbalance.

Things that can cause SIBO or make it more likely include:

Age. Older adults are at higher risk because they may make less of the gastric acid that breaks down food. They’re also more likely to have diverticulosis.

Anatomy. You may have a small intestine with an unusual shape. Physical differences in your gut can make food move more slowly than it should and allow bacteria to grow. These may happen because of:

• Diverticulosis (pouches in the small intestine)
• Surgical procedures like Roux-en-Y (gastric bypass surgery)
• Scar tissue from radiation or surgery
• Injury to your small intestine
• Unusual passage (fistula) between two parts of your bowel
• A buildup of protein called amyloid in your small intestine
• Blockages in the GI tract

Medical conditions like these can keep your intestines from working the way they should:

• Diabetes
• Lupus
• Connective tissue disorders such as scleroderma
• Weakened immune system because of HIV or an immunoglobulin A deficiency
• Inflammatory bowel diseases like Crohn’s and more rarely, ulcerative colitis

Medicines are sometimes at the root of SIBO. These may include:

• Narcotics
• Drugs that treat irritable bowel syndrome
• Proton pump inhibitors that curb acid in your stomach
• Antibiotics that affect the bacteria in your intestines

Symptoms of SIBO can look like those of many other conditions. If you’ve had symptoms that don’t go away, see a gastroenterologist. This type of doctor specializes in the digestive system.

They’ll probably order tests such as:

• Imaging tests like as X-rays, CT, or MRI to look for physical problems in your intestines
• Blood tests to check for anemia or a lack of vitamins
• Stool tests that look for problems like how much fat your body is absorbing
• Small intestine aspirate and fluid culture. Your doctor passes a long, thin tube called an endoscope through your digestive tract to your small intestine. They take a small sample of the fluid inside and do a lab test called a culture to see what kind of bacteria it has.
• Hydrogen breath test. First, you drink a sugary beverage. Over the next 3 hours, you breathe into a balloon every 15 minutes. This air is tested to see if it has high levels of hydrogen or methane to suggest SIBO.

To treat SIBO, you need to get your gut bacteria back in balance. That should ease your symptoms and help your body absorb more nutrients from your food.

The treatment might depend on the results of your breath test. If your sample had a lot of hydrogen in it, the main treatment is the antibiotic rifaximin (Xifaxan). If your test showed high levels of methane, you’ll probably take rifaximin plus the antibiotic neomycin (Mycifradin).

Other antibiotics that treat SIBO include:

• Amoxicillin-clavulanic acid (Augmentin)
• Ciprofloxacin (Cipro)
• Metronidazole (Flagyl)
• Norfloxacin (Noroxin)
• Trimethoprim-sulfamethoxazole (Bactrim)

You might need to take antibiotics for only a week or two, or for a longer time. Your doctor could also switch among several kinds.

SIBO can make it so your body doesn’t absorb enough of certain nutrients like vitamin B12, iron, thiamine, and niacin. Supplements may help.

Some people need surgery if their SIBO stems from a physical problem with their intestine. If this is the case, see your doctor regularly after the operation to check on your digestive health.

If you don’t have SIBO because of an anatomical problem, a simple step is to cut out sugary foods and drinks. This may be all it takes to feel better.

Other diet changes for SIBO include:

• Quitting foods that seem to make your symptoms worse and waiting 3 days before putting them back on your menu. This way, you’ll know whether a certain food triggers your symptoms.
• Avoiding fiber supplements as well as any liquid medications (such as cough syrup) that use sugar alcohols for flavor.
• Avoiding lactose. If your small intestine is damaged, you might lose the ability to digest lactose, the sugar in milk products.
• A low-FODMAP diet. FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. FODMAPs are a type of carbohydrate. But not every carb is a FODMAP. A nutritionist or a doctor experienced in nutrition can help you come up with the right plan.
• The elemental diet. This is an eating plan that involves special nutritional formulas instead of typical foods. They’re designed to meet your body’s nutritional needs.
• Prebiotics and probiotics. You can get probiotics in fermented foods like yogurt (look for “live, active cultures” on the label), kefir (a yogurt-based drink), and kimchi (a traditional Korean relish). To get more prebiotics from foods, include lots of fruits, veggies, and whole grains.

If you’re thinking about taking prebiotics or probiotics in supplements, talk with your doctor first to make sure they’re a good choice for you. Foods are always a good first step, since you’ll get lots of other nutrients that are good for you.

Without treatment, SIBO can lead to problems including:

• Lack of vitamins and nutrients
• Electrolyte imbalance
• Diarrhea
• Anemia
• Weight loss
• Weak bones (osteoporosis)
• Kidney stones

Top Picks

Bacterial Overgrowth Syndrome: Background, Pathophysiology, Epidemiology

1. Hao WL, Lee YK. Microflora of the gastrointestinal tract: a review. Methods Mol Biol. 2004. 268:491-502. [QxMD MEDLINE Link].

2. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28. 16(24):2978-90. [QxMD MEDLINE Link]. [Full Text].

3. Virally-Monod M, Tielmans D, Kevorkian JP, et al. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab. 1998 Dec. 24(6):530-6. [QxMD MEDLINE Link].

4. Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010 Dec. 24(4):943-59, viii-ix. [QxMD MEDLINE Link].

5. McEvoy A, Dutton J, James OF. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. Br Med J (Clin Res Ed). 1983 Sep 17. 287(6395):789-93. [QxMD MEDLINE Link].

6. Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008 Jul. 6(7):759-64. [QxMD MEDLINE Link].

7. Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease. Aliment Pharmacol Ther. 2003 Dec. 18(11-12):1107-12. [QxMD MEDLINE Link].

8. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009 Feb. 43(2):157-61. [QxMD MEDLINE Link].

9. webmd.com”>Ghoshal UC, Ghoshal U, Misra A, Choudhuri G. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol. 2004 May 22. 4:10. [QxMD MEDLINE Link].

10. Lewis SJ, Franco S, Young G, O’Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996 Aug. 10(4):557-61. [QxMD MEDLINE Link].

11. Elphick DA, Chew TS, Higham SE, Bird N, Ahmad A, Sanders DS. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier?. Gerontology. 2005 Nov-Dec. 51(6):396-401. [QxMD MEDLINE Link].

12. Hoverstad T, Bjorneklett A, Fausa O, Midtvedt T. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol. 1985 May. 20(4):492-9. [QxMD MEDLINE Link].

13. Kocoshis SA, Schletewitz K, Lovelace G, Laine RA. Duodenal bile acids among children: keto derivatives and aerobic small bowel bacterial overgrowth [published erratum appears in J Pediatr Gastroenterol Nutr 1988 Jan-Feb;7(1):155]. J Pediatr Gastroenterol Nutr. 1987 Sep-Oct. 6(5):686-96. [QxMD MEDLINE Link].

14. Chalmers RA, Valman HB, Liberman MM. Measurement of 4-hydroxyphenylacetic aciduria as a screening test for small-bowel disease. Clin Chem. 1979 Oct. 25(10):1791-4. [QxMD MEDLINE Link].

15. Sherr HP, Sasaki Y, Newman A, et al. Detection of bacterial deconjugation of bile salts by a convenient breath-analysis technic. N Engl J Med. 1971 Sep 16. 285(12):656-61. [QxMD MEDLINE Link].

16. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol. 2014 Dec. 12 (12):1964-72; quiz e119-20. [QxMD MEDLINE Link].

17. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G. Methodology and indications of h3-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009 Mar 30. 29 Suppl 1:1-49. [QxMD MEDLINE Link].

18. Hofmann AF. evaluation of bacterial overgrowth in the small intestine: how, when and why. In: Perri F, Andriulli A,editors. Clinical Application of Breath Tests in Gastroenterology and Hepatology. 1998.

19. Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion. 2000. 61(3):165-71. [QxMD MEDLINE Link].

20. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012 May. 57 (5):1321-9. [QxMD MEDLINE Link].

21. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020 Feb. 115 (2):165-178. [QxMD MEDLINE Link].

22. Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J Gastroenterol. 2009 Jun 7. 15(21):2628-31. [QxMD MEDLINE Link].

23. webmd.com”>Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009 Mar. 18(3):349-58. [QxMD MEDLINE Link].

24. Scarpellini E, Gabrielli M, Lauritano CE, Lupascu A, Merra G, Cammarota G. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007 Apr 1. 25(7):781-6. [QxMD MEDLINE Link].

25. Frissora CL, Cash BD. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Aliment Pharmacol Ther. 2007 Jun 1. 25(11):1271-81. [QxMD MEDLINE Link].

26. Tamer MA, Santora TR, Sandberg DH. Cholestyramine therapy for intractable diarrhea. Pediatrics. 1974 Feb. 53(2):217-20. [QxMD MEDLINE Link].

27. Vanderhoof JA, Young RJ. Etiology and pathogenesis of bacterial overgrowth. Clinical manifestations and diagnosis of bacterial overgrowth. Treatment of bacterial overgrowth UpToDate online, vol 18.1; Wellesley, 2010. http://www.uptodate.com. Available at http://www.uptodate.com.

28. Banwell JG, Sherr H. Effect of bacterial enterotoxins on the gastrointestinal tract. Gastroenterology. 1973 Sep. 65(3):467-97. [QxMD MEDLINE Link].

29. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006 Feb. 130(2 Suppl 1):S78-90. [QxMD MEDLINE Link].

30. Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010 Aug. 25 (8):1366-73. [QxMD MEDLINE Link].

31. McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017 Jul. 66 (7):1241-1251. [QxMD MEDLINE Link].

32. Marie I, Ducrotté P, Denis P, Menard JF, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford). 2009 Oct. 48 (10):1314-9. [QxMD MEDLINE Link].

33. Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol. 2017 Apr. 51 (4):300-311. [QxMD MEDLINE Link].

34. [Guideline] Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020 Feb. 115 (2):165-178. [QxMD MEDLINE Link].

35. [Guideline] Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017 May. 112 (5):775-784. [QxMD MEDLINE Link].

36. Hill ID, Mann MD, Househam KC, Bowie MD. Use of oral gentamicin, metronidazole, and cholestyramine in the treatment of severe persistent diarrhea in infants. Pediatrics. 1986 Apr. 77(4):477-81. [QxMD MEDLINE Link].

37. Abraczinskas D, Goldfinger SE. Intestinal gas and bloating. UpToDate on line, 18.1. Wellesley, 2010. http://www.uptodate.com. Available at http://www.uptodate.com.

38. webmd.com”>Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999 May. 94(5):1327-31. [QxMD MEDLINE Link].

39. Donald IP, Kitchingmam G, Donald F, Kupfer RM. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc. 1992 Jul. 40(7):692-6. [QxMD MEDLINE Link].

40. Elphick DA, Chew TS, Higham SE, Bird N, Ahmad A, Sanders DS. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier?. Gerontology. 2005 Nov-Dec. 51(6):396-401. [QxMD MEDLINE Link].

41. Gracey M, Burke V, Oshin A, et al. Bacteria, bile salts, and intestinal monosaccharide malabsorption. Gut. 1971 Sep. 12(9):683-92. [QxMD MEDLINE Link].

42. webmd.com”>Gregg CR. Enteric bacterial flora and bacterial overgrowth syndrome. Semin Gastrointest Dis. 2002 Oct. 13(4):200-9. [QxMD MEDLINE Link].

43. Haboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing. 1991 Jan. 20(1):29-32. [QxMD MEDLINE Link].

44. Kilby AM, Dolby JM, Honour P, Walker-Smith JA. Duodenal bacterial flora in early stages of transient monosaccharide intolerance in infants. Arch Dis Child. 1977 Mar. 52(3):228-34. [QxMD MEDLINE Link].

45. King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology. 1979 May. 76(5 Pt 1):1035-55. [QxMD MEDLINE Link].

46. Klish WJ, Udall JN, Rodriguez JT, et al. Intestinal surface area in infants with acquired monosaccharide intolerance. J Pediatr. 1978 Apr. 92(4):566-71. [QxMD MEDLINE Link].

47. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA. 2004 Aug 18. 292(7):852-8. [QxMD MEDLINE Link].

48. Mathias JR, Clench MH. Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine. Am J Med Sci. 1985 Jun. 289(6):243-8. [QxMD MEDLINE Link].

49. Meyers JS, Ehrenpreis ED, Craig RM. Small Intestinal Bacterial Overgrowth Syndrome. Curr Treat Options Gastroenterol. 2001 Feb. 4(1):7-14. [QxMD MEDLINE Link].

50. Nichols VN, Fraley JK, Evans KD, Nichols BL Jr. Acquired monosaccharide intolerance in infants. J Pediatr Gastroenterol Nutr. 1989 Jan. 8(1):51-7. [QxMD MEDLINE Link].

51. Saltzman JR, Russell RM. Nutritional consequences of intestinal bacterial overgrowth. Compr Ther. 1994. 20(9):523-30. [QxMD MEDLINE Link].

52. Tahan S, Melli LC, Mello CS, Rodrigues MS, Bezerra Filho H, de Morais MB. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum. J Pediatr Gastroenterol Nutr. 2013 Sep. 57 (3):316-8. [QxMD MEDLINE Link].

Bacterial overgrowth syndrome

Bacterial overgrowth syndrome (SIBO) in the small intestine and stomach increases the number of bacteria representing the normal microflora. In some cases, pathogenic microorganisms may appear in the composition of the microflora. This is possible after various operations on the stomach or intestines, with a violation of the motor activity of the intestine or a change in acidity in the stomach.

A change in the qualitative and quantitative composition of the microflora disrupts digestion and absorption, which causes diarrhea and loss of fats and vitamins with feces. Due to insufficient intake of vitamin B ₁₂ Anemia may develop.

Diagnosis uses breath tests and bacteriological examination of intestinal contents.

Treatment should be aimed not only at correcting the intestinal microflora, but also at the pathology that caused SIBO. In the absence of adequate therapy, the symptoms of the disease can persist for a long time.

Severe intoxication and malnutrition are likely in debilitated individuals, which can be life threatening.

Synonyms Russian

SIBO, small intestinal dysbiosis syndrome.

Synonyms English

Bacterial overgrowth syndrome, BOS, Bacterial overgrowth.

Symptoms

Some patients may not show symptoms for a long time. Its most common symptoms are:

• bloating and rumbling in the abdomen,
• diarrhea,
• periodic abdominal pain,
• nausea,
• weight loss.

Sometimes the symptoms of the disease are associated with impaired absorption of nutrients:

• general weakness, fatigue, pale skin, brittle nails and, as a result, anemia;
• leg cramps due to lack of potassium,
• visual impairment associated with vitamin A deficiency,
• peeling and redness of the skin (dermatitis) due to lack of selenium,
• changes in the nervous system in the form of sensitivity disorders, tingling associated with insufficient intake of vitamin B ₁₂ .

General information about the disease

Under normal conditions, the small intestine contains microorganisms that make up the normal microflora. They begin to populate the intestines after we are born and play an important role in digestion, the formation of the immune system, and in the growth and development of the body.

The main representatives of this flora are lactobacilli, enterococci, oral streptococci and other gram-positive bacteria.

The microflora changes in conditions that disrupt the functioning of the gastrointestinal tract and lead to the failure of protective mechanisms. Conditions are created for the active growth of some bacteria or the attachment of pathogenic flora, which is a syndrome of excessive bacterial growth.

Such conditions include chronic constipation, the consequences of surgical interventions on the intestines, fistulas, diverticula (saclike formations in the intestinal wall), which leads to a slowdown in motor activity and stagnation of intestinal contents.

Also, conditions for the spread of microorganisms are created in atrophic gastritis and as a result of long-term frequent courses of antisecretory drugs, when the stomach environment ceases to serve as a barrier to bacteria.

In case of congenital or acquired enzyme deficiency (pancreatitis, cholelithiasis) and nutrient absorption disorders (inflammation of the intestinal mucosa – Crohn’s disease, enteritis), excess nutrients serve as a soil for excessive growth of microorganisms.

Also, SIBO can develop against the background of immunodeficiency conditions (severe chronic diseases, infections, AIDS), when the function of immune defense cells in the intestine decreases.

If these mechanisms are not effective enough and the composition of the microflora changes, intestinal motility increases to remove excess bacteria in a timely manner, which leads to diarrhea and weight loss.

If the composition of the microflora is disturbed, the mucous membrane is affected and the functioning of the intestinal cells is disturbed, the absorption of nutrients worsens: proteins, fats, carbohydrates, vitamins, microelements. In addition, due to the excessive consumption of vitamin B 9 by microorganisms0005 12 possible anemia (caused by its lack in the blood) and changes in the nervous system. Often there is a deficiency of fat-soluble vitamins (A, D, E, K).

Microorganisms also interfere with the absorption of fats, resulting in greasy, hard-to-wash stools.

In case of insufficient absorption of selenium, the skin turns red and flaky.

In debilitated patients, SIBO causes malnutrition and intoxication, which can even lead to death.

Who is at risk?

• Elderly people.
• Patients undergoing upper gastrointestinal surgery.
• Patients with chronic diseases such as scleroderma or diabetes mellitus.
• Newborns or young children who are debilitated or have malformations of the gastrointestinal tract

Diagnosis

For diagnostic purposes, methods of examination of intestinal contents and breath tests are used.

The following tests may be used to detect impaired digestion and absorption.

• Complete blood count (without leukocyte formula and ESR). Hemoglobin may be low due to malabsorption of iron and vitamin B ₁₂ – this is a sign of anemia.
• Total protein. When absorption is impaired, its level in the blood decreases.
• Albumin. It accounts for most of the total protein, so the level of albumin is also reduced.
• Potassium, sodium, chlorine, calcium, iron. The amount of electrolytes may be below normal. A decrease in iron will also indicate anemia.
• Creatinine. It is a by-product of protein metabolism. In violation of their absorption, the body uses the proteins of its own tissues, which is accompanied by an increase in the level of creatinine in the blood and increased intoxication.
• Glucose. It reflects the amount of simple carbohydrates (sugar) entering the body, the absorption of which can also decrease, which, accordingly, will be manifested by a decrease in blood glucose levels.
• Vitamin B ₁₂ . Often its amount in the blood decreases, which, in combination with low hemoglobin, indicates the development of B ₁₂ -deficiency anemia.
• Vitamins A, D, E, K. Absorption of fat-soluble vitamins is often possible and their level in the blood decreases.
• Selenium. This test is especially important for changes in the skin (dermatitis), indicating a deficiency of this element.
• Coprogram. A study of feces, which makes it possible to judge the efficiency of digestion and absorption in the gastrointestinal tract. With SIBO, there will mainly be changes associated with impaired absorption of fats – an increase in the number of indicators such as soaps, neutral fats, salts of fatty acids in the coprogram.

The final diagnosis can be made with the help of:

• taking intestinal contents with a special probe for bacteriological examination, which allows you to study the quantitative and qualitative composition of the microflora, determine its sensitivity to antibiotics.

Various breath tests – an increase in the products secreted by the microbial flora in the exhaled air indicates a violation of its composition.

The scope of the examination is determined by the attending physician.

Treatment

Treatment is based on broad-spectrum antibiotics with a possible subsequent transition to those to which microorganisms are sensitive, which is determined after bacteriological examination of the intestinal contents.

Also of great importance is a diet aimed at enriching the body with nutrients. The intake of drugs that normalize the motor activity of the intestine, antidiarrheal and painkillers is shown.

Recommended tests

• CBC
• Serum potassium, sodium, chloride
• Serum calcium
• Serum iron
• Total protein in serum
• Serum albumin
• Serum creatinine
• Plasma glucose
• Vitamin B ₁₂ (cyanocobalamin)
• Fat soluble vitamins (A, D, E, K)
• Serum selenium
• Coprogram

Overview of Bacterial Overgrowth Syndrome

Epidemiology

Bacterial Overgrowth Syndrome (SIBO) is a condition in which bacteria that normally colonize the large intestine are present in excess in the small intestine in association with a constellation of gastrointestinal symptoms.

The human gastrointestinal tract has the largest microbial population in the human body ¹ ; the predominant part of the gastrointestinal tract is the large intestine, containing 38 trillion bacteria, according to the latest existing estimates ² . The term “microbiota” reflects the totality of all microorganisms that inhabit a particular part of the human body. Culture-independent microbiota studies, such as next-generation sequencing, have shown low concentrations of individual bacterial populations in the duodenum of healthy individuals, in contrast to bacterial populations inhabiting the mouth or lower intestines ³ . As you move along the small intestine, the concentration of bacteria progressively increases ^4.5 . This is due to the high acidity of gastric juice and peristaltic bowel movements.

The microbiology of the terminal ileum is an intermediate zone between the aerobic flora of the stomach and proximal small intestine and the dense population of anaerobic organisms found in the large intestine.